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Abstract
Background Several cell types are susceptible to transfection in vivo
using naked plasmid DNA. The mechanisms involved in mediating in vivo
transfection are incompletely known, but evidence suggests that receptor-
mediated endocytosis is important for specific types of cells. In this study we
tested the hypothesis that residual Escherichia coli lipopolysaccharide (LPS)
forms a non-covalent complex with expression plasmid DNA, and host-cell-
derived soluble LPS-binding proteins bind to the DNA-LPS complexes in order
to facilitate receptor-mediated endocytosis.
Methods Cells from the murine synovial lining were used as an in vivo
model system and in vivo luciferase imaging was used to quantify levels
of transgene expression. Using a series of gene-deleted mice, the roles of
LPS recognition complex proteins, lipopolysaccharide-binding protein (LBP),
CD14 and MD-2, in the process of in vivo transfection were determined.
Results Luciferase expression assays revealed that mice lacking LBP or CD14
had increased luciferase expression (p < 0.023 and <0.165, respectively),
while mice deleted of MD-2 had significant reductions in luciferase expression
(p < 0.001). Gene deletion of hyaluronic acid binding protein CD44 was used
as a control and had no statistically significant effect on transgene expression
in vivo. In muscle tissue, where neither cell surface nor soluble MD-2 is
expressed, no MD-2 dependence of plasmid transfection was identified,
suggesting the role of MD-2 is tissue or cell type specific. Additionally,
depleting mice of macrophages showed that luciferase expression is occurring
within fibroblast-like synoviocytes.
Conclusions Our data support a physical association between LPS and
E. coli-derived plasmid DNA, and that in vivo transfection of fibroblast-like
synoviocytes is dependent on the soluble form of the LPS-binding protein
MD-2. Copyright  2005 John Wiley & Sons, Ltd.
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Introduction
The observation that E. coli-derived plasmid DNA can mediate transfec-
tion of specific cell types in vivo was made initially in skeletal mus-
cle [1–5]. Subsequent studies have shown that other cell types are
amenable to in vivo transfection using E. coli-derived plasmid DNA with-
out additional delivery components. The cell types so far identified
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include thyroid follicular cells [6], salivary ductal cells
[7], follicular keratinocytes [8,9], hepatocytes [10,11],
and synovial fibroblasts [12,13].
Many of these studies have shown that the process
of DNA uptake and transfection is dose-dependent
and saturable [1,8]. These studies all suggest that
cellular uptake of E. coli-derived plasmid DNA occurs
via receptor-mediated endocytosis, although the exact
receptor(s) through which the DNA enters is unknown
[14]. Despite the widespread use of naked plasmid DNA as
a clinical gene transfer vector the mechanisms associated
with plasmid DNA uptake remain poorly understood [15].
The use of E. coli to derive expression plasmid DNA
as well as recombinant eukaryotic proteins is standard
in both the academic community and the pharmaceutical
industry. One of the primary safety concerns involved
in the use of E. coli-derived biological products is
contamination with Gram-negative lipopolysaccharide
(LPS). LPS is a potent biological molecule that exists
in the outer membrane of Gram-negative bacteria. It
is composed of a polysaccharide backbone linked to a
fatty acid moiety termed lipid A. The lipid A portion
is composed of a hydrophilic disaccharide bound to
multiple hydrophobic fatty acid chains, and upon binding
to host cell membranes, induces an endotoxic reaction in
humans [16,17]. The recognition of LPS as a potential
contaminant has prompted the US Food and Drug
Administration to mandate the testing of such products
intended for use in humans or animals for the presence of
endotoxin with the limulus amebocyte lysate test [18].
As LPS enters body fluids (e.g. serum, saliva, synovial
fluid) it first interacts with the plasma protein LPS-binding
protein (LBP), which catalyzes the binding of LPS to either
soluble or membrane-bound CD14 [19–22]. For the body
to generate an immune response signaling the presence of
bacterial LPS, CD14 in turn presents LPS to TLR-4, which
is the transmembrane signaling receptor for LPS [23].
TLR-4 requires a physical association with the adapter
protein MD-2 for expression, distribution, and proper
signaling of the presence of LPS [24–26].
In order to better understand the mechanisms
responsible for in vivo transfection with E. coli-derived
plasmid DNA, we hypothesized that residual Gram-
negative LPS forms a non-covalent complex with
plasmid DNA. In turn the putative LPS-DNA complex
is recognized by the cellular proteins that comprise
the LPS recognition complex and components that
facilitate receptor-mediated endocytosis. We and others
have shown previously that the synovial membrane is
susceptible to in vivo transfection following intra-articular
administration of expression plasmid DNA [12,27]. To
test our theory of DNA uptake we have developed an
in vivo synovial expression assay using a pCF1-luciferase
expression plasmid and an in vivo bioluminescent imaging
system. Purified plasmid was administered by intra-
articular injection into the stifle joints of both wild-type
control and gene-deleted mice that were deficient in
individual components of the LPS recognition complex.
Involvement of specific components in the process of
E. coli-derived plasmid DNA uptake was determined by
quantifying changes in luciferase expression levels in vivo
between the wild-type control and gene-deleted mice. The
changes detected in luciferase expression using our in vivo
expression assay under experimental conditions support
the inference that the cellular uptake of plasmid DNA is
modulated by recognition components of LPS.
Materials and methods
Plasmid DNA and endotoxin testing
The pCF1-luciferase (pCF1-Luc) plasmid, which contains
the cytomegalovirus promoter/enhancer region and
firefly (Photinus pyralis) luciferase gene, was purified
using an alkaline lysis procedure with the CONCERT
plasmid purification system (GibcoBRL, Gaithersburg,
MD, USA) according to the manufacturer’s instructions
[28]. The plasmid was further purified via cesium
chloride ultracentrifugation. Sheared salmon sperm DNA
(ss-DNA; Brinkmann Instruments Inc., Westbury, NY,
USA) was also isolated using cesium chloride gradient
ultracentrifugation performed contemporaneously with
the plasmid in order to isolate linear DNA that is similar
in size to that of the plasmid. Purified plasmid and ss-DNA
were tested for presence of endotoxin by a kinetic limulus
amebocyte lysate assay (LAL Kinetic-QCL; Biowhittaker,
Walkersville, MD, USA) prior to injections. E. coli-derived
plasmid DNA used in these experiments contained less
than 20 endotoxin units (EU) per milligram of DNA. All
reagents used were of high molecular grade to minimize
the possibility of contamination with LPS/endotoxin.
Synthetic, double-stranded oligonucleotides of 25 and
32 nt were produced by Integrated DNA Technologies,
Inc. (Coralville, IA, USA).
NMR
Deuterium oxide (D2O; Sigma-Aldrich, St. Louis, MO,
USA) was the solvent used for all samples analyzed.
The plasmid and salmon sperm DNA were prepared to
a concentration of 5 mg/ml, and the oligonucleotides
to 1 mg/ml. The LPS (Sigma-Aldrich) was prepared to
1 mg/ml and 2-fold serially diluted to generate a standard
curve. The oligonucleotides were analyzed both spiked
and not spiked with 0.125 mg/ml LPS. The biochemical
nuclear magnetic resonance (NMR) was performed with
a Bruker Avance DRX-500 NMR spectrometer with a 1H
NMR frequency of 500 MHz at the Nuclear Magnetic
Resonance Core (College of Pharmacy, University of
Michigan, USA).
Analysis of plasmid DNA for FAMEs
To 500 µl (1 mg) of each sample were added 100 µl of
a 17 : 0 fatty acid internal standard in 15 ml tapered,
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acid-cleaned Pyrex test tubes with Teflon-lined screw
caps. The pellet was extracted with a 1 : 2 : 1.5 ratio
of methanol/chloroform/0.1 M KCl in 50% methanol by
rigorous vortexing and subsequent centrifugation. The
organic phase was re-extracted with a 2.5× volume of
0.1 M KCl in 50% methanol. The organic phase was
then evaporated with N2 and transmethylated with 6%
methanolic-HCl for 3.5 h at 80 ◦C.
The sample was then prepared by one of two methods,
and each was analyzed. The subsequently formed fatty
acid methyl esters (FAMEs) were suspended in 200 µl
benzene, filtered using a 0.45 µm filter, and evaporated
with N2. Alternatively, the FAMEs in the methanolic-HCl
were further extracted using an equivalent volume of
petroleum ether, bp 30–60 ◦C, twice. After evaporation of
the sample with an N2 stream, the sample was suspended
in 200 µl benzene, filtered using a 0.45 µm filter and
evaporated with N2. The sample was resuspended in
100 µl of chloroform for analysis and injected in an aliquot
of either 0.6 or 1.0 µl.
The samples were analyzed using a Shimadzu gas
chromatography (GC) unit model GC-14A equipped with
a fused-silica Megabore DB225 column (0.53 micron
diameter) from J.W. Scientific (Folsom, CA, USA). A 21
fatty acid standard (Nu-CHEK-PREP, Inc., Elysian, MN,
USA) was used to calibrate the GC elution times and
to identify the fatty acids. The added 17 : 0 fatty acid
was used to quantitate the amount of fatty acid in the
samples. The flame ionization detector output of the gas
chromatograph was digitized by an IBM-PC computer
interface (model AN-146; Alpha Products, Darien, CT,
USA). Both the recording and data evaluation software
were created in BASIC or FORTRAN. The sensitivity of
the assay was between 0.5 and 1.0 µg/sample.
Mice
C57BL/6J wild-type controls, B6.129-CD44tm1Hbg CD44-
deficient, C57BL/10ScN TLR-4 deficient, and B6.129S-
Cd14tm1Frm CD14-deficient mice were purchased from The
Jackson Laboratory (Bar Harbor, ME, USA). LBP-deficient
mice were donated by Dr. Grace L. Su (University of
Michigan), and B6MD-2 −/− mice were kindly provided
by Dr. Kensuke Miyake (The University of Tokyo, Tokyo,
Japan). All mice were housed in the Unit for Laboratory
Animal Medicine at the University of Michigan. All
animal experiments were reviewed and approved by the




Five mice from each of the genotypes described
above were used. All experimental mice were treated
concurrently with an equal number of wild-type mice
as control. The mice were anesthetized, and the
knees and surrounding area were depilated using a
commercial hair remover. The mice were then injected
with 30 µg (6 µl at 5 µg/µl) of purified naked pCF1-Luc
plasmid intra-articularly into each stifle joint. Twenty-four
hours after plasmid DNA injections anesthetized mice
were imaged using the In vivo imaging System (IVIS;
Xenogen, Alameda, CA, USA) in the Michigan Small
Animal Imaging Resource (MSAIR), Center for Molecular
Imaging, Department of Radiology. Mice were imaged
for a 5-min luminescent integration time before and
after intra-peritoneal injection of the luciferase substrate,
a luciferin potassium salt in sterile phosphate-buffered
saline (PBS, 40 mg/ml) at a dose of 150 mg/kg body
weight. Mice were imaged again 15 min after the luciferin
injection. The photons emitted from the luminescence
reaction were detected as photons/second and depicted
as a pseudocolor overlay on a grayscale animal image for
easy visualization.
Intra-muscular injections
Two C57BL/6J mice and two B6MD-2 −/− mice were
intra-muscularly injected into each quadricep with 30 µg
(6 µl at 5 µg/µl) purified pCF1-Luc plasmid DNA as
above. Exactly as described above mice were imaged using
the IVIS 24 h post-plasmid administration and following
intra-peritoneal injection of the luciferin. Expression of
the luciferase protein was quantified as photons/second,
and mean levels were compared between the two groups.
Etoposide treatments
Etoposide was used to deplete synovial macrophages from
the synovial membrane [29] in order to determine which
of the two primary cells within the synovium, synovial
macrophages or fibroblast-like synoviocyte [30,31] was
undergoing transfection. Wild-type C57BL/6J mice were
treated with either sterile PBS (n = 4) or etoposide
(n = 4) by subcutaneous injection for 3 consecutive
days followed on day 4 by no treatment and intra-
articular plasmid injection. On day 5 they received another
dose of either PBS or etoposide a few hours prior to
synovial bioluminescent imaging. The etoposide dose was
12.5 mg/kg body weight. As above, luciferase expression
was quantified as photons/second, and mean values were
compared between the two groups. Knee joints of both
etoposide- and PBS-treated mice were removed and made
into 5 µm thick paraffin sections. Following treatment
to block endogenous peroxidase activity, sections were
stained with either purified anti-mouse CD14 antibody
(BD Pharmingen, San Diego, CA, USA) or no primary
antibody, and then photographed at 80× magnification.
Statistical methods
SPSS statistical software and Microsoft Excel were used
to analyze all data. In the in vivo bioluminescent assay
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plasmid expression was quantified as photons/second.
Pre-luciferin baseline values were subtracted from post-
luciferin values for each mouse. The experimental group
was then compared with the control with a t-test
comparing mean photons/second for each group.
Results
NMR
To analyze the association between DNA and LPS
we applied biochemical NMR to pure LPS, synthetic
oligonucleotides, sheared salmon sperm DNA, and E. coli-
derived plasmid DNA. Synthetic oligonucleotides were
used to avoid any naturally contaminating endotoxin.
Similarly, the salmon sperm DNA was used as a
comparison of like molecular weight to the pCF1-Luc
plasmid without contaminating endotoxin (although very
small amounts of endotoxin are unavoidable since it
is produced with E. coli-derived reagents). Figure 1A
shows the spectra of pure LPS at a concentration of
1.0 mg/ml. The oligonucleotides were analyzed at a
concentration of 1.0 mg/ml without (Figure 1B) and with
(Figure 1C) a 0.125 mg/ml spike of LPS. The spectrum
of the pure oligonucleotide was compared to that of
the oligonucleotide spiked with LPS and pure LPS by
overlaying the three spectra to identify peaks representing
LPS within the DNA sample (Figure 1D). There are distinct
peaks near 0.7, 1.1, 1.2, and 2.0 that appear both in
spectra of LPS and LPS-spiked oligonucleotides and that
are not in the unspiked oligonucleotides. These peaks are
representative of the protons of methyl groups at the end
of fatty acid chains similar to the fatty acid chains of the
lipid A portion of the LPS [32]. It is this lipid portion
that is known to bind to eukaryotic receptor components
to generate cellular immune responses [33,34]. We also
compared the spectra of pCF1-Luc and salmon sperm DNA
to that of serial dilutions of LPS attempting to determine
the stoichiometric relationship between LPS and plasmid.
However, the limitations in sample detection of the
spectrometer prevented analysis of the concentrations
of the LPS that exist in our plasmid DNA preparation
and in the commercially prepared salmon sperm DNA
(data not shown). Analysis of plasmid DNA for FAMEs
was designed to provide quantitative estimates of lipid
A/DNA stoichiometry. However, all of the DNA samples
evaluated had levels of FAMEs that were below the limits
of detection (0.5 µg per sample, data not shown).
Bioluminescent in vivo imaging
To identify the mechanism of in vivo transfection fol-
lowing intra-articular injection of E. coli-derived plasmid
DNA we quantified luciferase expression in a series of
gene-deleted mice. These included knockout mice for
LBP, CD14, TLR-4, and MD-2, all previously character-
ized as important functional signaling components of the
LPS recognition complex. Figure 2 shows the results of
the in vivo luciferase expression assays. Expression of the
luciferase is reported as photons/second, and the pseudo-
color gray scale images are representative of data obtained
from imaging of an individual animal.
As shown in Figure 2A, mice lacking functional LPS-
binding protein, LBP, have a significant increase in
luciferase expression as compared to wild-type mice. A
similar, although less significant, effect was observed
in CD14-deficient mice (Figure 2B). The involvement
of these two LPS-binding proteins in plasmid-mediated
transfection indicates that cytoplasmic uptake of pCF1-
Luc is linked functionally to recognition and trafficking of
LPS. This data strongly suggests a non-covalent complex
exists between LPS and plasmid DNA.
Figure 2C shows that mice deficient in the LPS
transmembrane signaling receptor TLR-4 produced no
change in luciferase expression. This suggests that TLR-4
is not directly involved in the endocytic uptake of the
hypothesized LPS-DNA complex, and confirms previous
data suggesting that internalization of LPS proceeds
through a cellular pathway distinct from TLR-4-mediated
signal transduction [35,36]. As a control for trafficked and
membrane-bound, as well as soluble, proteins within the
synovium we used the highly functionally and structurally
variable protein CD44. CD44 is widely expressed in
both fibroblast-like synoviocytes and chondrocytes, and
functions as a receptor for hyaluronic acid, the major
component of synovial fluid [37]. Because there is no data
suggesting that CD44 is involved in binding to LPS we
studied CD44 knockout mice to control for non-specific
interactions between LPS, plasmid DNA, and synovial
Figure 1. Biochemical 1H-NMR spectroscopy. All samples were dissolved in D2O and analyzed at a frequency of 500 MHz:
(A) pure LPS at 1.0 mg/ml; (B, C) synthetic oligonucleotides of different sequences, both at a concentration of 1.0 mg/ml. The
oligonucleotide in (C) is spiked with 0.125 mg/ml pure LPS. (D) Overlay of all three spectra to identify similar peaks (LPS, green;
oligo, red; spiked oligo, blue). Asterisks indicate distinct peaks seen in both LPS and LPS-spiked oligonucleotide but not in the
non-spiked oligonucleotide. This identical overlap identifies peaks representing LPS in DNA samples
Figure 2. In vivo expression assay in mice lacking LPS recognition components. Mice are intra-articularly injected with 30 µg
pCF1-Luc expression plasmid. Twenty-four hours post-injection luciferase levels are detected and quantified as photons/second
with the Xenogen In vivo imaging system (IVIS). Expression levels are compared between wild-type control mice and mice lacking
proteins of the LPS recognition complex; t-tests comparing these expression levels are used to determine p-values. For all images
the top mouse is the wild-type control and the bottom mouse is the experimental. (A) LBP knockout and (B) CD14 knockout mice
show a higher luciferase expression than from the wild-type controls. (C) TLR-4 knockout mice show no change in expression of
luciferase level from wild-type mice. (D) In mice lacking CD44, a major receptor in synovial tissue, but which does not bind LPS,
there is no difference in expression as compared to wild-type mice
Copyright  2005 John Wiley & Sons, Ltd. J Gene Med 2005; 7: 956–964.
960 J. A. Kolka, et al.
Figure 1.
Figure 2.
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Figure 3. MD-2-mediated plasmid DNA uptake in synovium. Both wild-type and MD-2 −/− mice were injected with 30 µg aqueous
pCF1-Luc expression plasmid into (A) synovial fluid or (B) muscle tissue. In both images, the top mouse is the control and the
bottom mouse is the experimental. In mice lacking MD-2 luciferase expression is significantly decreased in synovial tissue. In
muscle tissue, which does not express MD-2, there is no significant difference in expression. Luciferase expression is detected 24 h
following plasmid injection using the IVIS and quantified as photons/second; t-tests are used to determine p-values
Figure 4. Fibroblast-like synoviocytes are the major cell type responsible for plasmid uptake and expression in synovial tissue.
(A) C57BL/6J mice (n = 8) were treated by subcutaneous injection with either PBS (top mouse) or etoposide (bottom mouse) at
12.5 mg/kg for 3 consecutive days followed by intra-articular injection of plasmid DNA and bioluminescent imaging exactly as
described above. A fourth treatment dose was additionally given on the day of imaging. Mice depleted of macrophages from the
etoposide treatments exhibit increased luciferase expression compared to mice treated with PBS. Luciferase expression is quantified
as photons/second by the IVIS, and mean values are compared exactly as described above. (B) Paraffin sections of stifle joints from
etoposide- and PBS-treated mice were stained with purified anti-mouse CD14 antibody as a marker for macrophages. The synovial
tissue from mice treated with PBS as control was positive for CD14 (b), but CD14 is not present in synovial tissue from mice treated
with etoposide (d). (a, c) Synovial tissue from PBS- and etoposide-treated mice incubated without the CD14 antibody
Copyright  2005 John Wiley & Sons, Ltd. J Gene Med 2005; 7: 956–964.
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fluid. There were no statistically significant differences
in luciferase expression between CD44 knockouts and
wild-type controls. However, there was a trend toward
increased levels of luciferase expression in CD44 knockout
mice. This suggests the possibility that hyaluronic acid
binding proteins may also modulate transfection of
synovial cells via non-LPS-dependent mechanisms.
MD-2, in addition to being an essential cofactor to
TLR-4 for LPS signaling, has also been shown to bind
LPS [38] and exist in a soluble form [39]. As a protein
that is part of the LPS recognition complex and one that
specifically binds LPS we examined the role that MD-
2 plays in plasmid uptake and expression by looking
at luciferase expression levels of mice lacking MD-2
(Figure 3). Figure 3A compares luciferase expression of
MD-2 knockout mice to wild-type controls after intra-
articular injection, and shows there is a significant
decrease in luciferase expression in mice lacking MD-
2, suggesting a critical role for MD-2 in cytoplasmic
uptake and expression of plasmid DNA. To identify
possible tissue- and/or cell-specific utilization of MD-2 in
plasmid DNA transfection we examined in vivo luciferase
expression in skeletal muscle. Skeletal muscle has been
extensively studied as a target for DNA transfection
using naked plasmid DNA, and a variety of non-receptor-
mediated endocytic mechanisms for cytoplasmic entry
of plasmid DNA identified [1,4,12,13,40]. In addition,
skeletal muscle has been shown not to express MD-2
[24]. Figure 3B shows the results of the luciferase assay
in MD-2 knockout mice and wild-type control following
intra-muscular injection of the pCF1-Luc plasmid. We
observe no differences in luciferase expression in skeletal
muscle between wild-type mice and mice lacking MD-2,
suggesting that alternative pathways for plasmid DNA
internalization predominate in this tissue. This also
suggests that MD-2-mediated DNA uptake may be tissue
and/or cell type specific.
In order to clarify the identity of transfected cells within
the stifle joints we treated wild-type mice with etoposide
to deplete macrophages prior to treatment with intra-
articular pCF1-Luc plasmid followed by analysis with
the bioluminescent in vivo expression assay. Figure 4A
shows that mice depleted of macrophages show an
increase, although not statistically significant, in luciferase
expression as compared to mice treated with PBS as
control. To confirm etoposide-mediated depletion of
macrophages we harvested the stifle joints from treated
and control mice. Paraffin sections (saggatil) were stained
with anti-CD14 antibody as a marker for macrophages.
Figure 4B shows representative sections from the stifle
joints of both PBS- and etoposide-treated mice. Panel
(b) shows articular tissues from PBS-treated mice with
extensive positive staining for CD14, indicating the
presence of macrophages in both bone marrow and
synovium. Mice treated with etoposide had no evidence of
CD14-positive cells present within either the bone marrow
or synovium (panel d) indicating successful depletion of
macrophages. Control sections reacted with secondary
antibody alone showed no evidence of background
staining (panels a and c).
The intima of normal synovium is composed primarily
of synovial fibroblasts and synovial macrophages, with
very small percentages of resident dendritic cells
and lymphocytes [41]. These results suggest that the
majority of cellular uptake and expression of plasmid
DNA following intra-articular administration occurs in
fibroblast-like synoviocytes. However, it is also possible
that some percentage of subintimal fibroblasts or
endothelial cells of the subintimal vascular plexus may
also be susceptible to in vivo transfection and may
contribute to the overall level of luciferase expression
observed in vivo [41].
Discussion
It has been shown in numerous studies that plasmid
DNA can gain access to cytoplasm and nuclei of a
variety of cell types in vivo [1,8–13]. In specific cells
this occurs presumably through a process of receptor-
mediated endocytosis. However, the identities of the
cellular receptor(s) and mechanism(s) involved remain
incompletely understood. In these studies we have begun
to elucidate the role that E. coli-derived LPS, and the TLR-
4 accessory protein MD-2, play in the process of in vivo
transfection.
Plasmid DNA isolated from E. coli has physically
associated to it residual LPS from membranes of the
Gram-negative bacteria. Despite extensive purification
methods detectable amounts of functional LPS remain
in aqueous solutions of highly purified plasmid DNA.
Our data supports the hypothesis that there is a non-
covalent complex formed between plasmid DNA and
LPS. We believe that following in vivo administration
the DNA-LPS complex is recognized and bound to the
soluble LPS-binding proteins LBP, CD14, and MD-2.
Our data show that LBP and CD14 function to down-
modulate transfection whereas MD-2 appears to facilitate
transfection.
It is clear from the results of the sensitive bioassay
that small amounts of residual LPS are present in highly
purified preparations of plasmid DNA. Our expectation
was that the application of NMR spectroscopy and FAME
analyses would allow us to more precisely quantify the
amount of residual LPS present in association with highly
purified plasmid DNA and determine the stoichiometric
relationship between these components. Unfortunately,
the levels of residual LPS present in highly purified
preparations of plasmid DNA were either at or slightly
below the levels of detection of both NMR and FAME
analyses. In addition, these assays do not allow us to
verify our hypothesis that LPS and plasmid DNA may
exist in solution as a non-covalent complex, and that this
complex may have distinct biological properties that are
dependent on soluble proteins that are known to bind to
LPS in biological fluids. Our results are not completely
unexpected given the difficulty that other investigators
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have encountered in the application of biochemical or
biophysical methods to characterize the structure-function
relationships of LPS complexes [42]. At best we can use
the limits of detection for the FAME analyses to provide
us with an estimate of the levels of residual LPS. Based
on the limits of detection of the FAME analyses, the
absolute level of LPS per plasmid DNA is on the order
of 1.6 molecules of LPS per molecule of 5.5 kb plasmid
DNA. These analytical results provide indirect evidence
for the existence of a DNA-LPS complex, which supports
our in vivo data suggesting that plasmid DNA transfection
is modulated by interactions with soluble LPS-binding
proteins.
The in vivo bioluminescent expression experiments also
provide strong, although indirect, evidence supporting
the existence of complex formation between LPS and
plasmid DNA. This physical association is made evident
by the change in luciferase expression when plasmid
DNA is administered in vivo in the absence of LPS-
binding proteins. The normal functions of LBP and
CD14 are to facilitate transfer of LPS to the TLR-4-
MD-2 complex to signal an innate immune response.
The increase in luciferase expression observed in mice
deficient in either LBP or CD14 and the decrease in
expression in mice lacking MD-2 suggest that LBP and
CD14 compete with MD-2 for binding to plasmid DNA
through its association with LPS. Disparity between the
mechanisms of LPS signaling and endocytosis has been
previously recognized in several studies [35,43,44]. Our
results are consistent with previous studies showing that
CD14, in particular, functions as a competitive inhibitor
for endocytosis of purified LPS, and support the hypothesis
that soluble MD-2 is the protein that is responsible
for endocytosis of LPS. The magnitude of competition
between soluble CD14 and soluble MD-2 is not known;
however, our in vivo results are consistent with the
reported LPS-binding affinities for LBP (KD = 3.5 × 10−9)
and sCD14 (KD = 30–74 × 10−9) [21,45]. The binding
affinity between LPS and LBP is approximately 10 to
20 times greater than that between LPS and CD14,
which is reflected in the statistically, and non-statistically,
significant increase in luciferase expression in LBP- and
CD14-deficient mice, respectively. In the absence of
either LBP or CD14 we see a significant bias towards
LPS internalization and a resultant increase in luciferase
expression. This increase in protein expression observed in
the LBP and CD14 knockout mice supports the hypothesis
of complex formation between LPS and E. coli-derived
plasmid DNA.
MD-2 has proven to be required for proper cellular
distribution, and LPS recognition, by TLR-4. MD-2 has
also been shown to exist in a soluble form that can bind
LPS with a high binding affinity (KD = 65 × 10−9), similar
to that exhibited by CD14 [38,45]. Mice lacking MD-2
exhibited a significant decrease in luciferase expression
in vivo following intra-articular, but not intra-muscular,
administration of pCF1-Luc. This decrease in luciferase
expression observed in synovial tissue of MD-2 knockout
mice suggests that MD-2 in synovial tissue, probably
soluble MD-2 within synovial fluid, has an important
involvement in mediating internalization of plasmid DNA
through its ability to bind LPS. It is important to note
that skeletal muscle cells do not express high levels of
LPS-binding proteins including MD-2. In skeletal muscle
of MD-2 knockout mice we observed no change in plasmid
uptake and luciferase expression in the absence of MD-2.
This result supports the hypothesis that several non-
endocytic pathways of plasmid DNA uptake predominate
in skeletal muscle, and it supports the probable role
of soluble MD-2 within the synovial fluid. A direct
pathway by which synovial MD-2 binds to and mediates
internalization of LPS-DNA complexes is consistent with
the increases in luciferase expression that were observed
in the LBP and CD14 knockout mice. In this model LBP
and CD14 function as competitive inhibitors of MD-2.
In summary, we have identified a potential in vivo
mechanism that is used by E. coli-derived plasmid DNA
to gain entry into fibroblast-like synoviocytes that is
dependent on the LPS-binding protein MD-2. Further,
our data indicate that LBP and soluble CD14 function
as competitive inhibitors of in vivo transfection. These
results have important implications for the use of plasmid
DNA as both a clinical gene transfer vector system and
a vaccine. Many studies have examined the use of E.
coli-derived plasmid DNA as a vaccine; however, in vivo
results have often been inconsistent. It is interesting to
speculate that local concentrations of LBP, sCD14, and
MD-2 may influence pharmacodistribution of plasmid
DNA between signaling and endocytic pathways for LPS
processing used by antigen-presenting cells. In turn these
tissue- or cell-specific effects may influence global host
immune responses at both the innate and adaptive level.
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